ZEN Graphene Solutions Announces Exclusive Worldwide Rights to Commercialize Rapid, Saliva-Based COVID-19 Antigen Testing Technology
This release was issued on June 17, 2021 and speaks only as of that date. It has not been updated. For Zentek’s current disclosure, see SEDAR+ and EDGAR.
The full text of this release is available on the wire service.